This site is intended for healthcare professionals only

Tramadol accessibility should be reviewed

Written by: | Published:

Tramadol should be made a Class C drug, but still be available to those who require it on prescription, says the Advisory Council on the Misuse of Drugs (ACMD).

Tramadol is used to treat moderate to severe pain, including the treatment of fibromyalgia (chronic widespread pain), cancer pain and moderate to severe musculoskeletal pain. However as it is a psychoactive agent of the opioid class, it can be liable to misuse.

The government has accepted the ACMD's recommendation, subject to a public consultation, to ensure that those who need it will still have access to it under a process known as scheduling.

The crime prevention minister Jeremy Browne launched the consultation on 22 July.

Mr Browne said: ‘Tackling drug misuse is a key priority for this government. I am grateful for the advice from the ACMD in light of growing concerns around tramadol misuse. While it will continue to be available under prescription for those that need it, placing it in a schedule will mean access to the drug will be appropriately restricted.'

There are five schedules, with Schedule 1 containing the most restricted drugs considered to have little or no medicinal use such as LSD or ecstasy. Schedule 5 contains drugs that are available over the counter.

The ACMD recommends placing tramadol in Schedule 3. These drugs can be prescribed and legally possessed and supplied by doctors and pharmacists and must be stored in safes meeting minimum standards set out in law.

It also advises that healthcare professionals and prescribers who come into contact with people who use tramadol should be given appropriate training.

The consultation can be completed online and will close on 11 October 2013.

The number of deaths involving tramadol has risen from 83 in 2008 to 154 in 2011, according to data from the Office for National Statistics. The majority of tramadol related-deaths occurred where it has not been obtained through a prescription.

What do you think? Leave a comment below or tweet your views to @IndyNurseMag

This material is protected by MA Healthcare Ltd copyright.
See Terms and Conditions.



Please view our Terms and Conditions before leaving a comment.

Change the CAPTCHA codeSpeak the CAPTCHA code

Most read articles from Practice Nursing Journal

Practice Nursing Journal latest issue and most read articles.

Click here to read a selection of free to access articles from Practice Nursing Journal


Sign up to the newsletter


Independent Nurse is the professional resource for primary care and community nurses, providing clinical articles for practice nurses and prescribers.


Subscribe to our newsletter and stay up to date with the latest nursing news.

Stay Connected

Stay social with Independent Nurse by following us on Twitter, liking us on Facebook or connecting on LinkedIn.


Need access to some of our older articles? You can view our archive, or alternatively contact us.

Contact Us

MA Healthcare Ltd.
St Jude's Church, Dulwich Road
London, SE24 0PB

Tel: +44 (0)20 7738 5454
Registered in England and Wales No. 01878373

Meet the team


Find out how to contribute to Independent Nurse here.